Product Code: ANV2343
REPORT HIGHLIGHT
Precision Oncology Market size was valued at USD 69,584.67 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.
Precision oncology, also referred to as personalized or targeted cancer therapy, represents a tailored approach to cancer treatment, wherein medical interventions such as medications and treatment plans are customized to match the individual characteristics of each patient and their specific cancer subtype. This method considers various factors including the tumor's genetic makeup, molecular profile, and the patient's overall health, aiming to pinpoint the most effective treatment options with minimal side effects.
Precision Oncology Market- Market Dynamics
Technological advancements to propel market demand
Key drivers of market growth include technological advancements, a growing demand for diagnostic products delivering effective clinical results, thereby minimizing therapeutic side effects and preventing drug resistance. Similarly, expanding research activities, early detection of breast cancer, and overall patient prognosis are poised to bolster the demand for precision oncology. The COVID-19 pandemic has impacted the precision oncology market due to social distancing measures and lockdowns worldwide. Additionally, clinical trial studies were temporarily halted during the initial phase of the pandemic. However, post-pandemic, hospitals and clinics have experienced a decline in patient flow for precision oncology analysis along with therapeutic treatment. Delayed diagnosis and treatment using precision oncology have significantly affected cancer patient care.
Precision Oncology Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)
Based on Product Type segmentation, therapeutics was predicted to show maximum market share in the year 2023
Based on Indication Type segmentation, breast cancer was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Precision Oncology Market- Segmentation Analysis:
The Global Precision Oncology Market is segmented on the basis of Product Type, Indication Type, End Use, and Region.
The market is divided into two categories based on Product Type: diagnostics and therapeutics. In 2023, the therapeutics segment emerged as the market leader, propelled by factors such as the increasing amount of approvals for tumor-agnostic treatments and the unique characteristics of therapeutics tailored to specific proteins or mutations driving cancer growth. Precision oncology-based treatments offer patient-specific cancer treatment based on the DNA fingerprint of individually patient's cancer.
The market is divided into six categories based on Indication Type: breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, and others. In 2023, breast cancer held the largest market share, attributed to the growing focus on breast cancer screening, diagnosis, and advancements in surgical and radiation techniques. Additionally, expanding research endeavors, early detection of breast cancer, and improved patient prognosis are expected to drive the development of novel methods like precision oncology. Furthermore, the advent of advanced technologies for DNA sequencing has rapidly advanced the treatment of breast cancer patients.
Precision Oncology Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Precision Oncology Market- Competitive Landscape:
In the marketplace, companies specializing in precision oncology concentrate on innovating diagnostic tools, molecular profiling technologies, and targeted therapies to optimize cancer treatment outcomes. They allocate resources to research and development endeavors aimed at identifying biomarkers and genetic mutations associated with different cancer types, enabling more accurate diagnosis and treatment selection. Additionally, these companies may provide comprehensive genomic profiling services to healthcare providers, empowering them to make informed treatment decisions based on the molecular characteristics of the patient's tumor. Moreover, marketing initiatives seek to raise awareness among oncologists, healthcare providers, and patients regarding the benefits of precision oncology in enhancing treatment efficacy, minimizing adverse effects, and ultimately improving patient outcomes. Market players in the precision oncology sector are engaging in various innovative strategies such as agreements, new product launches, and expansions to bolster their market presence.
Recent Developments:
In December 2021, ConcertAI, LLC, along with LabCorp declared a collaboration aimed at enhancing precision oncology research. These companies are collaborating to launch clinical studies that will alleviate the burden on physician practices and improve patient retention, thereby ensuring equitable access to research as a care option and driving patient recruitment.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PRECISION ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Thermo Fisher Scientific Inc.
Invitae Corporation
Qiagen N.V.
Illumina, Inc.
Laboratory Corporation Of America Holding
Exact Sciences Corporation
Rain Oncology Inc.
Strata Oncology, Inc.
Xilis, Inc.
Variantyx, Inc.
Bioserve
Relay Therapeutics
Acrivon Therapeutics
Others
GLOBAL PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032
GLOBAL PRECISION ONCOLOGY MARKET, BY INDICATION TYPE- MARKET ANALYSIS, 2019 - 2032
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Prostate Cancer
- Lung Cancer
- Others
GLOBAL PRECISION ONCOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Healthcare Data Companies
GLOBAL PRECISION ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1.Precision Oncology Market Overview
- 1.1.Study Scope
- 1.2.Market Estimation Years
2.Executive Summary
- 2.1.Market Snippet
- 2.1.1.Precision Oncology Market Snippet by Product Type
- 2.1.2.Precision Oncology Market Snippet by Indication Type
- 2.1.3.Precision Oncology Market Snippet by End-Use
- 2.1.4.Precision Oncology Market Snippet by Country
- 2.1.5.Precision Oncology Market Snippet by Region
- 2.2.Competitive Insights
3.Precision Oncology Key Market Trends
- 3.1.Precision Oncology Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
- 3.2.Precision Oncology Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
- 3.3.Precision Oncology Market Opportunities
- 3.4.Precision Oncology Market Future Trends
4.Precision Oncology Industry Study
- 4.1.PEST Analysis
- 4.2.Porter's Five Forces Analysis
- 4.3.Growth Prospect Mapping
- 4.4.Regulatory Framework Analysis
5.Precision Oncology Market: COVID-19 Impact Analysis
- 5.1.Pre-COVID-19 Impact Analysis
- 5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments
6.Precision Oncology Market Landscape
- 6.1.Precision Oncology Market Share Analysis, 2023
- 6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis
7.Precision Oncology Market - By Product Type
- 7.1.Overview
- 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2.Diagnostics
- 7.1.3.Therapeutics
8.Precision Oncology Market - By Indication Type
- 8.1.Overview
- 8.1.1.Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
- 8.1.2.Breast Cancer
- 8.1.3.Colorectal Cancer
- 8.1.4.Cervical Cancer
- 8.1.5.Prostate Cancer
- 8.1.6.Lung Cancer
- 8.1.7.Others
9.Precision Oncology Market - By End-Use
- 9.1.Overview
- 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
- 9.1.2.Hospitals & Diagnostic Laboratories
- 9.1.3.Pharmaceutical & Biotechnology Companies
- 9.1.4.Healthcare Data Companies
10.Precision Oncology Market- By Geography
- 10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2.North America
- 10.2.1.Overview
- 10.2.2.Precision Oncology Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
- 10.2.7.1.Overview
- 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.7.4.U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
- 10.2.8.1.Overview
- 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.8.4.Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.Europe
- 10.3.1.Overview
- 10.3.2.Precision Oncology Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
- 10.3.7.1.Overview
- 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.7.4.Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
- 10.3.8.1.Overview
- 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.8.4.Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
- 10.3.9.1.Overview
- 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.9.4.United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.10.France
- 10.3.10.1.Overview
- 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.10.4.France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
- 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.11.3.Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
- 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.12.3.Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
- 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.13.3.Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
- 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.14.3.Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
- 10.3.15.1.Overview
- 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Precision Oncology Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.7.India
- 10.4.7.1.Overview
- 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.7.4.India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.8.China
- 10.4.8.1.Overview
- 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.8.4.China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
- 10.4.9.1.Overview
- 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.9.4.Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
- 10.4.10.1.Overview
- 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.10.4.South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
- 10.4.11.1.Overview
- 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.11.4.Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
- 10.4.12.1.Overview
- 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.12.4.Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
- 10.4.13.1.Overview
- 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.13.4.Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
- 10.4.14.1.Overview
- 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.14.4.Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
- 10.4.15.1.Overview
- 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Precision Oncology Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
- 10.5.7.1.Overview
- 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.7.4.Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
- 10.5.8.1.Overview
- 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.8.4.Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
- 10.5.9.1.Overview
- 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.9.4.Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
- 10.5.10.1.Overview
- 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.10.4.Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
- 10.5.11.1.Overview
- 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Precision Oncology Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
- 10.6.7.1.Overview
- 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
- 10.6.8.1.Overview
- 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
- 10.6.9.1.Overview
- 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.9.4.Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
- 10.6.10.1.Overview
- 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.10.4.Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
- 10.6.11.1.Overview
- 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.11.4.Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
- 10.6.12.1.Overview
- 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.12.4.Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
- 10.6.13.1.Overview
- 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
- 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
11.Key Vendor Analysis- Precision Oncology Industry
- 11.1.Competitive Dashboard
- 11.2.Company Profiles
- 11.2.1.Thermo Fisher Scientific Inc.
- 11.2.2.Invitae Corporation
- 11.2.3.Qiagen N.V.
- 11.2.4.Illumina, Inc.
- 11.2.5.Laboratory Corporation Of America Holding
- 11.2.6.Exact Sciences Corporation
- 11.2.7.Rain Oncology Inc.
- 11.2.8.Strata Oncology, Inc.
- 11.2.9.Xilis, Inc.
- 11.2.10.Variantyx, Inc.
- 11.2.11.Bioserve
- 11.2.12.Relay Therapeutics
- 11.2.13.Acrivon Therapeutics
- 11.2.14.Others
12.360 Degree Analyst View
13.Appendix
- 13.1.Research Methodology
- 13.2.References
- 13.3.Abbreviations
- 13.4.Disclaimer
- 13.5.Contact Us